Wells Fargo’s Minerva Neurosciences NERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,938
| Closed | -$3.29K | – | 7293 |
|
|
2025
Q1 | $3.29K | Hold |
1,938
| – | – | ﹤0.01% | 6090 |
|
|
2024
Q4 | $4.3K | Hold |
1,938
| – | – | ﹤0.01% | 6085 |
|
|
2024
Q3 | $5.17K | Hold |
1,938
| – | – | ﹤0.01% | 5910 |
|
|
2024
Q2 | $6.18K | Sell |
1,938
-1,043
| -35% | -$2.83K | ﹤0.01% | 5837 |
|
|
2024
Q1 | $7.69K | Buy |
2,981
+1,001
| +51% | +$6.14K | ﹤0.01% | 5818 |
|
|
2023
Q4 | $12.2K | Buy |
1,980
+2
| +0.1% | +$11 | ﹤0.01% | 5782 |
|
|
2023
Q3 | $13.6K | Buy |
1,978
+2
| +0.1% | +$18 | ﹤0.01% | 5725 |
|
|
2023
Q2 | $18.1K | Buy |
1,976
+1
| +0.1% | +$5 | ﹤0.01% | 5770 |
|
|
2023
Q1 | $3.16K | Buy |
1,975
+1
| +0.1% | +$2 | ﹤0.01% | 6156 |
|
|
2022
Q4 | $3.14K | Buy |
1,974
+1
| +0.1% | +$4 | ﹤0.01% | 5898 |
|
|
2022
Q3 | $18K | Sell |
1,973
-196
| -9% | -$1.16K | ﹤0.01% | 5452 |
|
|
2022
Q2 | $7K | Buy |
2,169
+200
| +10% | +$817 | ﹤0.01% | 5897 |
|
|
2022
Q1 | $13K | Buy |
1,969
+1,875
| +1,995% | +$11.5K | ﹤0.01% | 6175 |
|
|
2021
Q4 | $0 | Hold |
94
| – | – | ﹤0.01% | 7614 |
|
|
2021
Q3 | $1K | Buy |
94
+6
| +7% | +$90 | ﹤0.01% | 6751 |
|
|
2021
Q2 | $1K | Sell |
88
-78,589
| -100% | -$1.69M | ﹤0.01% | 6702 |
|
|
2021
Q1 | $1.84M | Buy |
78,677
+61,965
| +371% | +$1.55M | ﹤0.01% | 3772 |
|
|
2020
Q4 | $313K | Buy |
16,712
+12,482
| +295% | +$314K | ﹤0.01% | 4857 |
|
|
2020
Q3 | $108K | Sell |
4,230
-100
| -2% | -$2.7K | ﹤0.01% | 5231 |
|
|
2020
Q2 | $125K | Buy |
4,330
+1,984
| +85% | +$116K | ﹤0.01% | 5124 |
|
|
2020
Q1 | $113K | Buy |
2,346
+639
| +37% | +$38.6K | ﹤0.01% | 4999 |
|
|
2019
Q4 | $97K | Sell |
1,707
-123
| -7% | -$5.42K | ﹤0.01% | 5309 |
|
|
2019
Q3 | $114K | Sell |
1,830
-3,685
| -67% | -$209K | ﹤0.01% | 5258 |
|
|
2019
Q2 | $249K | Sell |
5,515
-958
| -15% | -$48K | ﹤0.01% | 4846 |
|
|
2019
Q1 | $407K | Sell |
6,473
-93
| -1% | -$5.59K | ﹤0.01% | 4454 |
|
|
2018
Q4 | $354K | Buy |
6,566
+4,780
| +268% | +$350K | ﹤0.01% | 4558 |
|
|
2018
Q3 | $180K | Buy |
1,786
+246
| +16% | +$18.5K | ﹤0.01% | 5061 |
|
|
2018
Q2 | $102K | Sell |
1,540
-104
| -6% | -$6.32K | ﹤0.01% | 5368 |
|
|
2018
Q1 | $82K | Buy |
1,644
+6
| +0.4% | +$288 | ﹤0.01% | 5390 |
|
|
2017
Q4 | $79K | Sell |
1,638
-580
| -26% | -$28.8K | ﹤0.01% | 5399 |
|
|
2017
Q3 | $135K | Buy |
2,218
+253
| +13% | +$14.5K | ﹤0.01% | 5107 |
|
|
2017
Q2 | $139K | Hold |
1,965
| – | – | ﹤0.01% | 5002 |
|
|
2017
Q1 | $127K | Hold |
1,965
| – | – | ﹤0.01% | 5087 |
|
|
2016
Q4 | $185K | Buy |
1,965
+1,290
| +191% | +$132K | ﹤0.01% | 4817 |
|
|
2016
Q3 | $76K | Hold |
675
| – | – | ﹤0.01% | 5075 |
|
|
2016
Q2 | $55K | Buy |
675
+625
| +1,250% | +$39.7K | ﹤0.01% | 5162 |
|
|
2016
Q1 | $2K | Buy |
+50
| New | +$2.13K | ﹤0.01% | 6036 |
|
Other funds holding NERV
AC
ACM
Wells Fargo's NERV Position: Q2 2025 in Review
Wells Fargo sold out of Minerva Neurosciences (NERV) in Q2 2025, closing a stake of 1,938 shares — an estimated $3.29K sold.
Wells Fargo first reported a position in NERV in Q1 2016 and held it in 37 quarters. The position peaked at $1.84M in Q1 2021. 21 funds tracked by Wall St. Rank hold NERV as of Q2 2025.
- Wells Fargo reported no remaining Minerva Neurosciences position as of Q2 2025 after selling out during the quarter.
- Wells Fargo sold 1,938 Minerva Neurosciences shares in Q2 2025, an estimated $3.29K.
- Wells Fargo first reported a position in Minerva Neurosciences in Q1 2016 and held it in 37 quarters.
- Wells Fargo's Minerva Neurosciences position peaked at $1.84M in Q1 2021.
- 21 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2025.
Based on Wells Fargo's 13F filing for Q2 2025, filed 14 Aug 2025.